Effect of disease-modifying antirheumatic drug therapy on immune response to trivalent influenza vaccine in rheumatoid arthritis

BACKGROUND & OBJECTIVES: Patients with autoimmune rheumatic diseases may be at an increased risk of infection due to disease and use of disease-modifying antirheumatic drug (DMARD) therapy. The present study was done to evaluate the immune response to influenza vaccination in patients with rheum...

Descripción completa

Detalles Bibliográficos
Autores principales: Jain, Vikramraj K., Bhashini, Nandhini, Balajee, L. Karthik, Sistla, Sujatha, Parija, Subhash Chandra, Negi, Vir Singh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663159/
https://www.ncbi.nlm.nih.gov/pubmed/28862177
http://dx.doi.org/10.4103/ijmr.IJMR_920_15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663159/
https://www.ncbi.nlm.nih.gov/pubmed/28862177
http://dx.doi.org/10.4103/ijmr.IJMR_920_15

Ejemplares similares